130 related articles for article (PubMed ID: 38809890)
1. Impact of integrative care on cardiovascular disease risk in newly diagnosed type 2 diabetes mellitus patients: A BI-VitalLife Cohort study.
Khunlertkit T; Viangteeravat T; Wangprapa P; Siriwechdaruk S; Ford JM; Pongpirul K
PLoS One; 2024; 19(5):e0302438. PubMed ID: 38809890
[TBL] [Abstract][Full Text] [Related]
2. Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.
Sattar N; Rawshani A; Franzén S; Rawshani A; Svensson AM; Rosengren A; McGuire DK; Eliasson B; Gudbjörnsdottir S
Circulation; 2019 May; 139(19):2228-2237. PubMed ID: 30955347
[TBL] [Abstract][Full Text] [Related]
3. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cardiovascular events in patients with newly diagnosed acute coronary syndrome: Influence of diabetes and its management with medication.
Komaru Y; Takeuchi T; Suzuki L; Asano T; Urayama KY
J Diabetes Complications; 2020 Mar; 34(3):107511. PubMed ID: 31928892
[TBL] [Abstract][Full Text] [Related]
5. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study.
Wong CK; Wong WC; Wan YF; Chan AK; Chung KL; Chan FW; Lam CL
Diabetes Obes Metab; 2015 Feb; 17(2):128-35. PubMed ID: 25251664
[TBL] [Abstract][Full Text] [Related]
6. 10-Year Cardiovascular Risk in Patients With Newly Diagnosed Type 2 Diabetes Mellitus.
Gyldenkerne C; Mortensen MB; Kahlert J; Thrane PG; Warnakula Olesen KK; Sørensen HT; Thomsen RW; Maeng M
J Am Coll Cardiol; 2023 Oct; 82(16):1583-1594. PubMed ID: 37821168
[TBL] [Abstract][Full Text] [Related]
7. Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Peng CH; Yang YS; Chan KC; Kornelius E; Chiou JY; Huang CN
Intern Med; 2017; 56(9):1015-1021. PubMed ID: 28458305
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study.
Fu AZ; Qiu Y; Radican L; Yin DD; Mavros P
Cardiovasc Diabetol; 2010 Apr; 9():15. PubMed ID: 20409333
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal association between egg consumption and the risk of cardiovascular disease: interaction with type 2 diabetes mellitus.
Jang J; Shin MJ; Kim OY; Park K
Nutr Diabetes; 2018 Apr; 8(1):20. PubMed ID: 29695709
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.
Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW
Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999
[TBL] [Abstract][Full Text] [Related]
11. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
12. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
13. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes.
Engelen SE; van der Graaf Y; Stam-Slob MC; Grobbee DE; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
Int J Cardiol; 2017 Dec; 248():301-307. PubMed ID: 28802735
[TBL] [Abstract][Full Text] [Related]
15. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
16. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
Fung CSC; Wan EYF; Chan AKC; Lam CLK
BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
[TBL] [Abstract][Full Text] [Related]
17. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients.
Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PM; Johansson G
Diabetes Metab; 2013 Sep; 39(4):306-13. PubMed ID: 23871502
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.
Kim SC; Glynn RJ; Liu J; Everett BM; Goldfine AB
Acta Diabetol; 2014 Dec; 51(6):1015-23. PubMed ID: 25311055
[TBL] [Abstract][Full Text] [Related]
19. Association between cardiovascular disease risk and incident type 2 diabetes mellitus in individuals with prediabetes: A retrospective cohort study.
Kim MJ; Cho YK; Jung CH; Lee WJ
Diabetes Res Clin Pract; 2024 Feb; 208():111125. PubMed ID: 38309535
[TBL] [Abstract][Full Text] [Related]
20. A lower eGFR
Yang Y; Yang B; Zhao S; Liu S; Zhou H; Xu N; Yang M
Ren Fail; 2024 Dec; 46(2):2346267. PubMed ID: 38905298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
